Title
Efficacy of psychological interventions on clinical outcomes of coronary artery disease: Systematic review and meta-analysis
Date Issued
01 February 2022
Access level
metadata only access
Resource Type
review
Author(s)
Magán I.
Jurado-Barba R.
Casado L.
Barnum H.
Jeon A.
Bueno H.
Publisher(s)
Elsevier Inc.
Abstract
Objectives: Psychological factors influence clinical outcomes in patients with coronary artery disease (CAD). Therefore, psychological interventions (PIs) may have beneficial effects in these patients. We evaluated the efficacy of PIs based on cognitive-behavioral therapy (CBT) and positive psychology therapy (PPT) on clinical and laboratory outcomes in CAD. Methods: Randomized controlled trials evaluating CBT or PPT in CAD patients published until May 2020 were systematically reviewed and analyzed. Primary outcomes were all-cause mortality, cardiovascular mortality, any cardiovascular event, myocardial infarction (MI), stroke, coronary revascularization, angina, and readmission. Random effects meta-analyses using the inverse variance method were performed. Effects were expressed as risk ratios (RR) or standardized mean difference (SMD) with 95% confidence intervals (CIs). Results: Twenty-five trials were included (n = 8119); 22 evaluating the effects of multi-component CBT (n = 7909), and three PPT (n = 210). Thirteen RCTs were at high risk of bias due to limitations in randomization or blinding. Compared with control groups any cardiovascular event (RR 0.82; 0.70 to 0.97; 5 studies), MI (RR 0.72; 0.52 to 0.98; 9 studies), and angina duration and intensity (SMD -0.64; −0.98 to −0.30; 4 studies; and −0.64; −1.17 to −0.11; 2 trials) were significantly reduced with PIs at the end of follow-up. PIs had no effect on other primary outcomes, laboratory or anthropometrical results and presented a moderate to high heterogeneity. Conclusions: CBT- and PPT-based PIs reduce the risk of cardiovascular events, MI and angina in patients with CAD. Future research should assess the individual role of CBT and PPT in CAD populations.
Volume
153
Language
English
OCDE Knowledge area
Psicología (incluye terapias de aprendizaje, habla, visual y otras discapacidades físicas y mentales) Sistema cardiaco, Sistema cardiovascular
Scopus EID
2-s2.0-85122266836
PubMed ID
Source
Journal of Psychosomatic Research
ISSN of the container
00223999
Sponsor(s)
None. None of the authors have conflicts of interests with public or private entities related to the content of this manuscript. Dr. Bueno receives research funding from the Instituto de Salud Carlos III , Spain ( PIE16/00021 & PI17/01799 ), Astra-Zeneca , BMS and Novartis ; has received consulting fees from Amgen, Astra-Zeneca, Bayer, BMS-Pfizer, Novartis; and speaking fees or support for attending scientific meetings from Astra-Zeneca, Bayer, BMS-Pfizer, Novartis, and MEDSCAPE-theheart.org . Dr. Jurado receives research funding from the Ministerio de Ciencia, Innovación y Universidades , Spain ( PSI2015-68851-P ). Dr. Magán, Dr. Jurado, and Dr. Bueno have received funding from Universidad Camilo José Cela , Madrid – Spain (2015-18 and 2021–22). Dr. Hernandez is supported by the Agency for Healthcare Research and Quality ( AHRQ HHSA290201500012I ).
Sources of information: Directorio de Producción Científica Scopus